Ghezzi, Chiara <br/><br/>
A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells.  [electronic resource] 

 -  Nature communications  11 2019 
 - 5444 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-019-13334-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Carcinoma, Non-Small-Cell Lung--metabolism<br/>Cell Line, Tumor<br/>Class I Phosphatidylinositol 3-Kinases--drug effects<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Glucose--metabolism<br/>Glucose Transporter Type 1--drug effects<br/>High-Throughput Screening Assays<br/>Humans<br/>Lung Neoplasms--metabolism<br/>Phenylenediamines--pharmacology<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology<br/>Quinazolines--pharmacology<br/>RNA Polymerase II--drug effects<br/>RNA, Messenger--metabolism<br/>Signal Transduction<br/>Triazines--pharmacology<br/>Cyclin-Dependent Kinase-Activating Kinase